Optimal care and cutting-edge research are only possible in a network.

This is particularly true for research into rare CHIP mutations. The necessary national and international cooperation requires structures that guarantee patient-oriented research based on the highest ethical standards.

Currently, the university hospitals of the DZHK, hospitals and research institutes with a focus on CHIP, as well as colleagues in private practice, patient representatives and scientists are involved in the constantly growing competence network.